White Paper

3 Simple Tips For Finding A CRO With IND Application Know-How

Source: QPS LLC

The U.S. Food and Drug Administration reports having received a higher number of applications for investigational new drugs (INDs) in the past few years. Only a handful of years ago, the number of IND applications received annually was hovering in the 300-400 range. Yet, in the 2018 fiscal year, the FDA received 675 IND applications. And 487 applications were submitted in just the first three quarters of 2019. This rise in IND applications is part of a trend of growing biotech investment that is boosting drug discovery and development around the globe.

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader